TY - JOUR T1 - Characterization of Proflavine Metabolites in Rainbow Trout JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 431 LP - 436 VL - 25 IS - 4 AU - Zhengrong Yu AU - William L. Hayton AU - Kenneth K. Chan Y1 - 1997/04/01 UR - http://dmd.aspetjournals.org/content/25/4/431.abstract N2 - Proflavine (3,6-diaminoacridine) has potential for use as an antiinfective in fish, and its metabolism by rainbow trout was therefore studied. Fourteen hours after intraarterial bolus administration of 10 mg/kg of proflavine, three metabolites were found in liver and bile, and one metabolite was found in plasma using reversed-phase HPLC with UV detection at 262 nm. Treatment with hydrochloric acid converted the three metabolites to proflavine, which suggested that the metabolites were proflavine conjugates. Treatment with β-glucuronidase and saccharic acid 1,4-lactone, a specific β-glucuronidase inhibitor, revealed that two metabolites were proflavine glucuronides. For determination of UV-VIS absorption and mass spectra, HPLC-purified metabolites were isolated from liver. Data from these experiments suggested that the proflavine metabolites were 3-N-glucuronosyl proflavine (PG), 3-N-glucuronosyl,6-N-acetyl proflavine (APG), and 3-N-acetylproflavine (AP). The identities of the metabolites were verified by chemical synthesis. When synthetic PG and AP were compared with the two metabolites isolated from trout, they had the same molecular weight as determined by matrix-assisted, laser desorption ionization, time-of-flight MS. In addition, they coeluted on HPLC under different mobile phase conditions. Finally, the in vitro incubation with liver subcellular preparations confirmed this characterization and provided the evidence that APG can be formed by glucuronidation of AP or acetylation of PG. The American Society for Pharmacology and Experimental Therapeutics ER -